US EditionPublished • loading... • Updated
Catalonia Captures Health Investment with the Support of Multinationals Like Astrazeneca
Summary by The Objective | Periodismo Ethos
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The Catalan ecosystem of life sciences has consolidated its position as one of the most dynamic poles in Europe, reaching in 2025 a record of 517 million euros in attracting foreign investment, according to the BioRegion of Catalonia 2025 Report prepared by Biocat. Between 2021 and 2025, the BioRegion accumulated a total of 2,382 million euros, a figure that has been driven by the strategic commitment of AstraZeneca, since 73% of this investment…
·Madrid, Spain
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
